Home/Pipeline/Infectious Diseases

Infectious Diseases

ClinicalActive

Key Facts

Indication

Infectious Diseases

Phase

Clinical

Status

Active

Company

Menarini

About Menarini

Menarini is a major, privately-held European pharmaceutical company with a diversified portfolio spanning pharmaceuticals, consumer healthcare, diagnostics, and derma-aesthetic medicine. It leverages a fully integrated model from R&D to global commercial execution, with a significant strategic focus on oncology and a strong partnering heritage. The company is actively investing in advanced science to build a pipeline for serious conditions while maintaining a core commitment to its values and corporate responsibility.

View full company profile

Therapeutic Areas

Oncology Anti Infectives Cardiometabolic Respiratory & Allergology Gastrointestinal Disorders Pain Men's Health Dermatology Aesthetic Medicine

Other Infectious Diseases Drugs

Drug	Company	Phase	Status
inPROBE Platform	SDS Optic	Early R&D	Active
Potential Human POC Diagnostics	MatMaCorp	Research	Active
Nanoparticle Vaccines	Opko Health	Research	Active
Platform Vaccine Applications	Chimeron Bio	Discovery	Research
FMN riboswitch modulator	Acellera	Pre-clinical	Hit Identification
NP-G2-044	Novita Pharmaceuticals	Pre-Clinical	Exploratory
Ramoplanin™	Nanopharmaceutics	Clinical	Active
NanoDOX™	Nanopharmaceutics	Clinical	Active
Undisclosed Infectious Disease Program(s)	ATB therapeutics	Pre-clinical	Active
Vaccines for Infectious Diseases (undisclosed)	Takis	Pre-clinical	Active
Infectious Disease Diagnostics Program	Aptus Biosciences	Discovery	Active
Undisclosed Multispecific Therapeutics	ModeX Therapeutics	Pre-clinical	Active